| Ind-Swift Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532305 |
NSE Symbol : INDSWFTLAB |
P/E(TTM) : 25.85 |
|
ISIN Demat : INE915B01019 |
Div & Yield% : 0.00 |
EPS(TTM) : 3.71 |
|
Book Value(₹) : 159.13 |
Market Cap(₹Cr) : 782.65 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 150.44 | 147.99 | 144.75 | 121.54 | 2.71 | 30.46 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 150.44 | 147.99 | 144.75 | 121.54 | 2.71 | 30.46 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 17.86 | 14.58 | 220.29 | 16.63 | 12.95 | 11.14 |
| Total Income | 168.30 | 162.58 | 365.04 | 138.18 | 15.65 | 41.60 |
| Total Expenditure | 148.25 | 144.92 | 158.21 | 123.20 | 14.71 | 34.99 |
| PBIDT | 20.05 | 17.65 | 206.83 | 14.98 | 0.95 | 6.61 |
| Interest | 2.01 | 1.15 | -26.76 | 10.03 | 0.41 | 0.17 |
| PBDT | 18.03 | 16.50 | 233.58 | 4.95 | 0.54 | 6.44 |
| Depreciation | 6.98 | 6.68 | 7.44 | 5.81 | 0.22 | 0.25 |
| Tax | 2.30 | 1.71 | 11.88 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | -3.83 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 8.76 | 8.12 | 218.09 | -0.86 | 0.32 | 6.19 |
| Extra-ordinary Items | 0.00 | 0.00 | 204.54 | -0.73 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 8.76 | 8.12 | 13.55 | -0.13 | 0.32 | 6.19 |
| EPS (Unit Curr.) | 1.10 | 1.18 | 32.34 | -0.13 | 0.05 | 1.05 |
| EPS (Adj) (Unit Curr.) | 1.10 | 1.18 | 32.34 | -0.13 | 0.05 | 1.05 |
| Calculated EPS (Unit Curr.) | 1.07 | 1.18 | 31.72 | -0.13 | 0.05 | 1.05 |
| Calculated EPS (Adj) (Unit Curr.) | 1.07 | 1.18 | 31.72 | -0.13 | 0.05 | 1.05 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.29 | 4.72 | 126.90 | -0.51 | 0.22 | 4.19 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.29 | 4.72 | 126.90 | -0.51 | 0.22 | 4.19 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 81.61 | 68.74 | 68.74 | 67.21 | 59.09 | 59.09 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 13.33 | 11.93 | 142.89 | 12.33 | 35.06 | 21.70 |
| PBDTM(%) | 11.98 | 11.15 | 161.37 | 4.07 | 19.93 | 21.14 |
| PATM(%) | 5.82 | 5.49 | 150.67 | -0.71 | 11.81 | 20.32 |